Maternal and Child Health Bureau, Health Resources and Services Administration Department of Health and Human Services, Rockville, Maryland.
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention Department of Health and Human Services, Atlanta, Georgia.
JAMA. 2021 Jan 12;325(2):146-155. doi: 10.1001/jama.2020.24991.
Substantial increases in both neonatal abstinence syndrome (NAS) and maternal opioid use disorder have been observed through 2014.
To examine national and state variation in NAS and maternal opioid-related diagnoses (MOD) rates in 2017 and to describe national and state changes since 2010 in the US, which included expanded MOD codes (opioid use disorder plus long-term and unspecified use) implemented in International Classification of Disease, 10th Revision, Clinical Modification.
DESIGN, SETTING, AND PARTICIPANTS: Repeated cross-sectional analysis of the 2010 to 2017 Healthcare Cost and Utilization Project's National Inpatient Sample and State Inpatient Databases, an all-payer compendium of hospital discharge records from community nonrehabilitation hospitals in 47 states and the District of Columbia.
State and year.
NAS rate per 1000 birth hospitalizations and MOD rate per 1000 delivery hospitalizations.
In 2017, there were 751 037 birth hospitalizations and 748 239 delivery hospitalizations in the national sample; 5375 newborns had NAS and 6065 women had MOD documented in the discharge record. Mean gestational age was 38.4 weeks and mean maternal age was 28.8 years. From 2010 to 2017, the estimated NAS rate significantly increased by 3.3 per 1000 birth hospitalizations (95% CI, 2.5-4.1), from 4.0 (95% CI, 3.3-4.7) to 7.3 (95% CI, 6.8-7.7). The estimated MOD rate significantly increased by 4.6 per 1000 delivery hospitalizations (95% CI, 3.9-5.4), from 3.5 (95% CI, 3.0-4.1) to 8.2 (95% CI, 7.7-8.7). Larger increases for MOD vs NAS rates occurred with new International Classification of Disease, 10th Revision, Clinical Modification codes in 2016. From a census of 47 state databases in 2017, NAS rates ranged from 1.3 per 1000 birth hospitalizations in Nebraska to 53.5 per 1000 birth hospitalizations in West Virginia, with Maine (31.4), Vermont (29.4), Delaware (24.2), and Kentucky (23.9) also exceeding 20 per 1000 birth hospitalizations, while MOD rates ranged from 1.7 per 1000 delivery hospitalizations in Nebraska to 47.3 per 1000 delivery hospitalizations in Vermont, with West Virginia (40.1), Maine (37.8), Delaware (24.3), and Kentucky (23.4) also exceeding 20 per 1000 delivery hospitalizations. From 2010 to 2017, NAS and MOD rates increased significantly for all states except Nebraska and Vermont, which only had MOD increases.
In the US from 2010 to 2017, estimated rates of NAS and MOD significantly increased nationally and for the majority of states, with notable state-level variation.
自 2014 年以来,新生儿戒断综合征(NAS)和产妇阿片类药物使用障碍的数量都大幅增加。
在 2017 年,我们检查了美国全国和各州的 NAS 和产妇阿片类药物相关诊断(MOD)的发病率,并描述了自 2010 年以来美国的全国和各州的变化情况,其中包括在 2010 年实施的国际疾病分类,第 10 次修订版,临床修正版中的扩展 MOD 编码(阿片类药物使用障碍加上长期和未指明的使用)。
设计、地点和参与者:2010 年至 2017 年,我们对医疗保健成本和利用项目的全国住院患者样本和州住院患者数据库进行了重复的横断面分析,该数据库是来自 47 个州和哥伦比亚特区的社区非康复医院出院记录的全付费汇编。
州和年份。
每 1000 次分娩住院的 NAS 率和每 1000 次分娩住院的 MOD 率。
在全国样本中,2017 年有 751037 次分娩住院和 748239 次分娩住院;在出院记录中,有 5375 名新生儿出现 NAS,6065 名妇女出现 MOD。平均孕龄为 38.4 周,平均产妇年龄为 28.8 岁。从 2010 年到 2017 年,估计的 NAS 率显著增加了 3.3 每 1000 次分娩住院(95%可信区间,2.5-4.1),从 4.0(95%可信区间,3.3-4.7)到 7.3(95%可信区间,6.8-7.7)。估计的 MOD 率显著增加了 4.6 每 1000 次分娩住院(95%可信区间,3.9-5.4),从 3.5(95%可信区间,3.0-4.1)到 8.2(95%可信区间,7.7-8.7)。在 2016 年,新的国际疾病分类,第 10 次修订版,临床修正版的代码中,MOD 与 NAS 比率的增加更大。从 2017 年的 47 个州数据库普查来看,NAS 率从内布拉斯加州的每 1000 次分娩住院 1.3 到西弗吉尼亚州的每 1000 次分娩住院 53.5 不等,缅因州(31.4)、佛蒙特州(29.4)、特拉华州(24.2)和肯塔基州(23.9)也超过了每 1000 次分娩住院 20 次,而 MOD 率从内布拉斯加州的每 1000 次分娩住院 1.7 到佛蒙特州的每 1000 次分娩住院 47.3 不等,西弗吉尼亚州(40.1)、缅因州(37.8)、特拉华州(24.3)和肯塔基州(23.4)也超过了每 1000 次分娩住院 20 次。从 2010 年到 2017 年,除了内布拉斯加州和佛蒙特州只出现 MOD 增加外,所有州的 NAS 和 MOD 发病率都显著增加。
在美国,从 2010 年到 2017 年,NAS 和 MOD 的估计发病率在全国范围内和大多数州都显著增加,各州之间存在显著差异。